ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 112 filers reported holding ALBIREO PHARMA INC in Q3 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $19,990,763 | +11.6% | 925,070 | -0.0% | 0.01% | 0.0% |
| Q3 2022 | $17,914,000 | +3.3% | 925,304 | +6.0% | 0.01% | +11.1% |
| Q2 2022 | $17,335,000 | +21.5% | 872,898 | +82.5% | 0.01% | +50.0% |
| Q1 2022 | $14,267,000 | +101.4% | 478,303 | +57.3% | 0.01% | +100.0% |
| Q4 2021 | $7,084,000 | -16.3% | 304,152 | +12.1% | 0.00% | 0.0% |
| Q3 2021 | $8,465,000 | -11.3% | 271,307 | 0.0% | 0.00% | -25.0% |
| Q2 2021 | $9,545,000 | +8.3% | 271,307 | +8.5% | 0.00% | 0.0% |
| Q1 2021 | $8,813,000 | -6.0% | 250,007 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $9,378,000 | +12.4% | 250,007 | +0.0% | 0.00% | 0.0% |
| Q3 2020 | $8,343,000 | – | 250,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 198,800 | $5,266,000 | 2.26% |
| Perceptive Advisors | 1,960,139 | $51,924,000 | 0.84% |
| Chicago Capital, LLC | 502,212 | $13,304,000 | 0.77% |
| Birchview Capital, LP | 48,000 | $1,272,000 | 0.77% |
| Artal Group S.A. | 500,360 | $13,255,000 | 0.37% |
| HEARTLAND ADVISORS INC | 150,000 | $3,974,000 | 0.35% |
| Eversept Partners, LP | 78,029 | $2,066,988 | 0.28% |
| ArrowMark Colorado Holdings LLC | 956,990 | $25,351,000 | 0.26% |
| PA Capital LLC | 12,987 | $344,000 | 0.25% |
| Ikarian Capital, LLC | 100,500 | $2,662,000 | 0.21% |